about
Artemisinin combination therapy for vivax malariaResults of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trialFidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virusClinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated.Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.Oral artesunate dose-response relationship in acute falciparum malariaMalaria on the World Wide Web.Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control studyThe association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cellsInterferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand.Interruption of antiretroviral therapy is associated with increased plasma cystatin CEarly treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations.Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection.Connection domain mutations in treatment-experienced patients in the OPTIMA trial.A family with adult-onset cerebral adrenoleucodystrophy.Travel medicine has come of age and a new examination marks the 21st birthday.Protein and energy metabolism in chronic bacterial infection: studies in melioidosis.Malaria: severe, life-threateningImproved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detectionA Randomized Study Comparing Combined Pneumococcal Conjugate and Polysaccharide Vaccination Schedules in AdultsBritish HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patientsDysuria and a headacheCutaneous Tuberculosis of the Penis and Sexual Transmission of Tuberculosis Confirmed by Molecular TypingTILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individualsInterleukin 2 treatment in HIV-1 infectionInvestigation of the role of typhoid toxin in acute typhoid fever in a human challenge modelTreatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model
P50
Q24622539-D5A8FF21-F7FD-4508-B007-9545DA1D805DQ28477586-33090A12-5988-4020-951C-37D1B52C82CFQ30425705-E9C79C75-F93C-49A2-96C0-FD82FE95C40FQ30430587-41912F25-2A28-4D6B-AF63-186C9258BF7DQ33627682-D38348D9-23C9-46DB-B001-B7EE307C5653Q33962303-7B77545F-8ED3-4DC8-B170-D4B5AA502473Q34113505-DEE019B5-0695-4BA2-A2FD-7A932706460FQ34326452-D4F0C7B3-CFA0-49B1-9A31-01F1D8AE64C5Q34606647-3A41629C-B19E-4093-AF13-F4B2766E5489Q34611788-473BA929-4F07-4BB9-8188-5585C355CC48Q34625248-2B289C44-F0A6-4803-822D-5F526315152FQ35685124-2CCA8920-6878-44A8-BDA4-85AEF02B7AADQ35883435-D01B1A4C-C1E1-4F81-9CF4-EFC6ED825E8EQ36949893-8DC3FF7C-0102-471D-8368-806A00ABF83AQ37014184-DFCD3B00-2130-4A31-930C-7003FA46358FQ37386153-04757F37-3F0B-4767-8B20-B672FA8C80D3Q39301017-5766648B-76A5-4564-BFF8-353E6926A505Q42280583-5AEFE183-4A2F-4DC1-824D-1E3D74833A76Q43174477-1E69FDE8-ED8E-455D-9F56-D8BC2B355F80Q48097496-CF7A0C16-B89F-4CCA-A139-0B5FCCEF3993Q49056577-773A9058-901E-4B8D-A8D2-E9844B1509C0Q51552219-907C0FDC-6CC6-4513-B75E-504092D9AADAQ56771228-C94ABAFA-1120-4370-88A2-3DF8E8F10972Q57676428-5D6FC36D-C3F8-4322-9D10-8229BAA25B5CQ58493013-8C33A7A6-1BCA-4577-BAE9-FB34B5B8CD09Q59650717-5C85702F-1377-4D1D-83AD-6A66C51EFDCDQ61439957-84103642-A5FD-474C-BD4F-880B4F99D858Q61439972-D435CCB2-4E88-42F4-95B0-0BBC53AB0A56Q61439973-CB0DA874-B17F-448D-8BA0-8FA28F83296AQ80925634-49D66943-558C-4BD7-AF67-2E5E9CC3D00FQ83040717-BEEFC24E-33E3-4D07-9F37-591AE930CD54Q91595626-0AD0A342-EDFC-4576-8BF8-FF80D330DBA4Q92251974-09D0B9F4-B9EB-4724-86FA-995D2AD833F6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brian J Angus
@ast
Brian J Angus
@en
Brian J Angus
@es
Brian J Angus
@nl
Brian J Angus
@sl
type
label
Brian J Angus
@ast
Brian J Angus
@en
Brian J Angus
@es
Brian J Angus
@nl
Brian J Angus
@sl
prefLabel
Brian J Angus
@ast
Brian J Angus
@en
Brian J Angus
@es
Brian J Angus
@nl
Brian J Angus
@sl
P106
P21
P31
P496
0000-0003-3598-7784